BlackRock’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
118,507
+32,360
+38% +$270K ﹤0.01% 4236
2026
Q1
$553K Buy
86,147
+26,215
+44% +$125K ﹤0.01% 4503
2025
Q4
$199K Sell
59,932
-33,073
-36% -$93.5K ﹤0.01% 4724
2025
Q3
$184K Sell
93,005
-85,672
-48% -$165K ﹤0.01% 4692
2025
Q2
$266K Sell
178,677
-278,694
-61% -$475K ﹤0.01% 4601
2025
Q1
$755K Sell
457,371
-10,071
-2% -$27.1K ﹤0.01% 4273
2024
Q4
$1.61M Buy
467,442
+58,783
+14% +$1.86M ﹤0.01% 4092
2024
Q3
$18.2M Buy
408,659
+66,390
+19% +$2.44M ﹤0.01% 3100
2024
Q2
$6.14M Buy
342,269
+297,696
+668% +$7.12M ﹤0.01% 3614
2024
Q1
$760K Sell
44,573
-15,989
-26% -$220K ﹤0.01% 4278
2023
Q4
$663K Sell
60,562
-898
-1% -$13.1K ﹤0.01% 4359
2023
Q3
$1.29M Sell
61,460
-44
-0.1% -$897 ﹤0.01% 4157
2023
Q2
$980K Sell
61,504
-5,359
-8% -$96.2K ﹤0.01% 4299
2023
Q1
$1.24M Sell
66,863
-5,780
-8% -$144K ﹤0.01% 4258
2022
Q4
$1.65M Sell
72,643
-18,209
-20% -$483K ﹤0.01% 4214
2022
Q3
$2.63M Sell
90,852
-1,186
-1% -$48.4K ﹤0.01% 4050
2022
Q2
$3.26M Sell
92,038
-122,959
-57% -$4.2M ﹤0.01% 4010
2022
Q1
$11.8M Buy
214,997
+15,676
+8% +$974K ﹤0.01% 3489
2021
Q4
$13.1M Buy
199,321
+6,486
+3% +$630K ﹤0.01% 3513
2021
Q3
$27.3M Buy
192,835
+6,272
+3% +$799K ﹤0.01% 3077
2021
Q2
$24.4M Buy
186,563
+27,389
+17% +$3.42M ﹤0.01% 3179
2021
Q1
$27M Buy
159,174
+5,666
+4% +$1.19M ﹤0.01% 3018
2020
Q4
$31.2M Buy
153,508
+1,276
+0.8% +$247K ﹤0.01% 2764
2020
Q3
$29.3M Sell
152,232
-3,872
-2% -$868K ﹤0.01% 2641
2020
Q2
$42.7M Buy
156,104
+39,065
+33% +$10.4M ﹤0.01% 2349
2020
Q1
$32.7M Sell
117,039
-2,509
-2% -$768K ﹤0.01% 2324
2019
Q4
$44.5M Buy
119,548
+646
+0.5% +$185K ﹤0.01% 2439
2019
Q3
$38.7M Buy
118,902
+3,116
+3% +$1.06M ﹤0.01% 2439
2019
Q2
$40.8M Buy
115,786
+37,926
+49% +$14.9M ﹤0.01% 2444
2019
Q1
$38.9M Sell
77,860
-3,276
-4% -$1.46M ﹤0.01% 2407
2018
Q4
$32.7M Buy
81,136
+46,505
+134% +$17.6M ﹤0.01% 2463
2018
Q3
$14.2M Buy
34,631
+5,132
+17% +$1.74M ﹤0.01% 3051
2018
Q2
$10.8M Buy
+29,499
New +$10.6M ﹤0.01% 3198

Other funds holding QTTB

BlackRock's QTTB Position: Q2 2026 in Review

BlackRock increased its Q32 Bio (QTTB) stake by 38% in Q2 2026, buying an estimated $270K and bringing the position to 118,507 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #4236.

BlackRock first reported a position in QTTB in Q2 2018 and has held it in 33 quarters since. The position peaked at $44.5M in Q4 2019. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • BlackRock held 118,507 shares of Q32 Bio worth $1.51M as of Q2 2026.
  • BlackRock bought 32,360 Q32 Bio shares in Q2 2026, an estimated $270K.
  • Q32 Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4236 holding.
  • BlackRock first reported a position in Q32 Bio in Q2 2018 and has held it in 33 quarters since.
  • BlackRock's Q32 Bio position peaked at $44.5M in Q4 2019.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.